What is Bimo data?
The FDA Bioresearch Monitoring Program (BIMO) develops guidelines for inspections of clinical investigators, sponsors, and Institutional Review Boards (IRBs).
What is BIMO in clinical trials?
FDA’s Bioresearch Monitoring (BIMO) program is a comprehensive program of on-site inspections and data audits designed to monitor all aspects of the conduct and reporting of FDA regulated research.
What Bimo means?
BIMO
| Acronym | Definition |
|---|---|
| BIMO | Benign Idiopathic Macro-Orchidism |
Why was Bimo created?
The BIMO Program was established to assure the quality and integrity of data submitted to the agency in support of new product approvals, as well as, to provide for protection of the rights and welfare of the thousands of human subjects involved in FDA regulated research.
What are the common deficiencies found during FDA site audits?
The most common deficiencies cited for inspections were failure to follow investigational plan (n = 3,202, 33.8% of all inspections), followed by inadequate informed consent form (n = 2,661, 28.1%), inadequate and inaccurate records (n = 2,562, 27.0%), inadequate drug accountability (n = 1,437, 15.2%), and failure to …
What are three common FDA inspection findings for clinical investigators?
What does an FDA audit involve?
The Food and Drug Administration (FDA) conducts inspections and assessments of regulated facilities to determine a firm’s compliance with applicable laws and regulations, such as the Food, Drug, and Cosmetic Act. This typically involves an investigator visiting a firm’s location.
When FDA conducts an inspection the inspectors will?
When the FDA conducts an inspection, the inspectors will: Review regulatory records. The overall goal of monitoring, audits, and inspection activities is to: Ensure the protection of human research subjects and data integrity.
Who inspects clinical trials?
FDA
FDA is authorized at reasonable times to access, inspect, and copy any required records related to the clinical investigation. See section 704 of the Federal Food, Drug, and Cosmetic Act (21 USC 374), 21 CFR 312.68, and 21 CFR 812.145.
What triggers an FDA audit?
“For Cause” inspections are performed when other information, such as product quality complaints, adverse events or data from an application or other source, indicate a potential problem with a firm’s products that warrants a more timely investigation.
What happens if you fail an FDA audit?
Official action indicated (OAI) – Inspectors found violations that require mandatory corrective action. The FDA will place regulatory and/or administrative sanctions on your business if these are not corrected.
